Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

6/21/2019 Database Update: Pharmaceutical Drug Production in Russia (May 2019)

Between January and May 2019, Russia produced 157.5 bln RUB worth of pharmaceutical drugs (manufacturers’ dispatch prices, VAT included), which is in monetary terms (rubles) 19.1% higher than that of the same period in 2018. While the dynamics are positive, they are still significantly lower than those of 2018. These dynamics are due to May’s negative dynamics in monetary terms and low positive in physical terms.

5/29/2019 Database Update: Pharmaceutical Drug Production in Russia (April 2019)

Between January and April 2019, Russia produced 127.4 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms (rubles) 26.3% higher than that of the same period in 2018. These high dynamics are due not only to inflation but also to high production volume in physical terms (+4.1%).

4/24/2019 Database Update: Pharmaceutical Drug Production in Russia (March 2019)

Between January and March 2019, Russia produced 86.9 bln RUB worth of pharmaceuticals (manufactures’ dispatch prices, VAT included), which is in monetary terms 14.7% higher than that of the same period of 2018. However, the dynamics in physical terms are only +0.5% (1.01 bln units).

3/28/2019 Database Update: Pharmaceutical Drug Production in Russia (February 2019)

Between January and February 2019, Russia produced 53.6 bln RUB worth of pharmaceuticals (dispatch prices, VAT included), which is in monetary terms 14.3% higher than that of the same period in 2018. In physical terms, the dynamics are -1.5%, with 651.5 mln units.

3/6/2019 Database Update: Pharmaceutical Drug Production in Russia (January 2019)

January 2019 saw the typical seasonal decrease, with the dynamics of the dispatched Russian pharmaceutical drug production being -24% in monetary terms and -26% in physical terms. However, the dynamics of the total Russian pharmaceutical drug production are +6.5% in monetary terms and +2.7% in physical terms.

All news [32]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.